Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer

HD of pemetrexed maintenance treatment in patients with advanced nsqNSCLC was feasible, safe, and preferred by patients, while maintaining HRQoL. Physicians were satisfied with distant patient management.